CVS Health宣布2026-2027季更新版新冠疫苗已在全美门店及MinuteClinic上线

CVS Health (CVS) announced that updated 2026-2027 COVID-19 vaccines are now available at CVS Pharmacy and MinuteClinic locations across the United States, with most patients able to receive them at no cost through insurance coverage.
The company emphasized convenience as a key priority, offering appointments through CVS.com, MinuteClinic.com, and the CVS Health app, while also accepting walk-ins at retail locations. "We know patients value having convenient access to the vaccines and preventive care services they need," said Amy Compton-Phillips, MD, Executive Vice President and Chief Medical Officer, CVS Health. "With updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic, we're making it easier for people to get vaccinated close to home and on a schedule that works for them."
Vaccinations are available for eligible patients based on state regulations, with MinuteClinic offering vaccines for individuals as young as 18 months. Pharmacists and providers are available to answer questions and guide patients in making informed decisions based on their health needs.
Appointments can be scheduled seven days a week, including evenings and weekends, with options for families and caregivers to book up to four people at once. Patients may also receive multiple recommended vaccines during a single visit, including flu and RSV shots.
For uninsured patients, costs vary depending on product type and eligibility, while CVS continues to monitor vaccination requirements in states such as Arizona, Louisiana, and Oregon.
CVS Health, which operates approximately 9,000 retail pharmacy locations and more than 1,000 walk-in and primary care clinics, said the initiative reflects its broader mission to simplify healthcare access and improve outcomes through integrated, technology-driven services.
This rollout marks another step in expanding preventive care nationwide, ensuring updated COVID-19 protection is available to millions of Americans ahead of the 2026-2027 season.
CVS has traded between $69.51 and $110.68 over the past year. The stock closed Thursday's trading at $97.20, down 0.03%. During the overnight trading session, the stock is at $97.72, up 0.53%.
For comments and feedback contact: editorial@rttnews.com
Business News
August 28, 2026 14:11 ET Consumer prices data and economic output figures were the main news on the economics front in the U.S. this week. Similarly, latest data on demand for durable goods also drew attention. Survey data on the business morale in the biggest euro economy, Germany, were in focus in Europe. In Asia, the interest rate announcement from South Korea was the highlight.